- Home
- CADL vs TSAT Comparison
CADL vs TSAT Comparison
Compare CADL & TSAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- TSAT
- Stock Information
- Founded
- CADL 1999
- TSAT 1969
- Country
- CADL United States
- TSAT Canada
- Employees
- CADL 38
- TSAT N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- TSAT Metal Fabrications
- Sector
- CADL Health Care
- TSAT Industrials
- Exchange
- CADL Nasdaq
- TSAT Nasdaq
- Market Cap
- CADL 252.0M
- TSAT 233.1M
- IPO Year
- CADL 2021
- TSAT 1996
- Fundamental
- Price
- CADL $5.10
- TSAT $26.10
- Analyst Decision
- CADL Strong Buy
- TSAT
- Analyst Count
- CADL 5
- TSAT 0
- Target Price
- CADL $21.40
- TSAT N/A
- AVG Volume (30 Days)
- CADL 923.7K
- TSAT 156.2K
- Earning Date
- CADL 08-12-2025
- TSAT 08-13-2025
- Dividend Yield
- CADL N/A
- TSAT N/A
- EPS Growth
- CADL N/A
- TSAT N/A
- EPS
- CADL N/A
- TSAT N/A
- Revenue
- CADL N/A
- TSAT $372,642,710.00
- Revenue This Year
- CADL N/A
- TSAT N/A
- Revenue Next Year
- CADL N/A
- TSAT N/A
- P/E Ratio
- CADL N/A
- TSAT N/A
- Revenue Growth
- CADL N/A
- TSAT N/A
- 52 Week Low
- CADL $3.79
- TSAT $7.21
- 52 Week High
- CADL $14.60
- TSAT $26.14
- Technical
- Relative Strength Index (RSI)
- CADL 44.91
- TSAT 73.17
- Support Level
- CADL $4.73
- TSAT $22.35
- Resistance Level
- CADL $5.07
- TSAT $26.00
- Average True Range (ATR)
- CADL 0.28
- TSAT 1.77
- MACD
- CADL -0.01
- TSAT 0.42
- Stochastic Oscillator
- CADL 48.38
- TSAT 96.29
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About TSAT Telesat Corporation and Class B Variable Voting Shares
Telesat Corp is a satellite operator, that provides its customers with mission-critical communications services. It operates in a single operating segment, in which it provides satellite-based services to its broadcast, enterprise, and consulting customers around the world. Geographically, it derives a majority of its revenue from Canada. It derives revenue from Broadcast, Enterprise, Consulting, and others.